chartexchange

Kyverna Therapeutics Announces Completion of BLA Submission for Miv-cel in Stiff Person Syndrome and Reports Third Quarter 2026 Financial Results

GlobeNewswire Inc. | Nov 12, 2026 8:00 AM EST

BLA submission for miv-cel in SPS completed with request for priority review 

Read original article